Skip to content

Psyon’s Mission

Psyon – Psychedelic Clinic is a psychotherapy-oriented centre that focuses on psychotherapy and psychedelic therapy. This includes the following 3 primary areas:


Psychotherapeutic counselling: We currently provide psychotherapeutic counselling covering a broad spectrum of situations and difficulties that people can encounter in their lives. Our therapists employ an extensive range of psychotherapeutic styles and approaches in order to provide effective help to people dealing with psychological issues, psychosomatic conditions, relationship problems, as well as assistance in personal development.


Psychedelics – psychological support and assistance: We provide psychological help for complications and issues that may have arisen out of previous use of psychedelic substances. We offer professional help with the so-called integration process of the experience. The goal of such integration is not only to mitigate and prevent unwanted complications but also to help the clients capitalize on the transformational potential of these experiences in their personal development.



Psychedelic-assisted psychotherapy (PAP): As part of the expanding global interest in the therapeutic potential of psychedelics among medical professionals, Psyon’s goal is to also function as a healthcare facility offering the so-called psychedelic-assisted psychotherapy (PAP), doing so in accordance with the applicable law, along with providing specialized education and training for therapists in this field.


We are a therapy centre, which draws on our knowledge of a wide range of current psychotherapy techniques in order to help facilitate personal growth and development and treat mental health issues. Our current emphasis is on providing therapeutic help on an individual basis. In the future, we plan to also include group therapy sessions. Our approach to therapy is consistently non-dogmatic – our therapists select the most appropriate method and technique based on the client’s individual needs. We believe that even negative experiences can often help with one’s personal development and facilitate a deeper insight into the world and into one’s self. This is why our motto is “openness to experience”. We also welcome discussions of even the most difficult and often shied away from topics that can be encountered, including those related to the finiteness of our own existence.


Psychedelics is a term used to refer to a highly specific group of psychoactive substances that induce altered states of consciousness and can have a significant long-term impact on the experiencing of emotions and psychological functioning. These substances act as non-specific amplifiers of psychological processes and thus can be useful in the treatment of various types of mental illness. Despite their illegal status, psychedelics are used by large numbers of people. These substances are rarely associated with specific health risks, which are mostly psychological. Psychologists, psychiatrists and psychotherapists often lack the skills and knowledge necessary to work with the potential complications that can arise out of the use of these substances. There is a particular shortage of trained personnel with the specific skills needed to help people with the issues arising out of psychedelic use in such a way as to allow them to gain benefits from such use and avoid any long-term negative consequences. Psyon is committed to helping improve society’s awareness of psychedelics in cooperation with the Czech Psychedelic Society (CZEPS) and the Foundation for Psychedelic Science (PSYRES).


PAP is an innovative approach to mental health care. Currently, it is not an official procedure; however, the evidence of its effectiveness is continuing to grow. This approach involves the use of psychedelic substances which, where appropriate, facilitates the psychotherapeutic process. Psychotherapy remains to be the framework and essence of the treatment. In the future, Psyon plans to offer comprehensive ketamine-assisted psychotherapy in indicated cases (e.g. in treatment-resistant depression). We are also looking into the possibility of employing other psychedelic substances in psychotherapy. The US Food and Drug Administration (FDA) has granted substance-assisted psychotherapy (with MDMA for post-traumatic stress disorder and psilocybin for depression) the status of a “breakthrough therapy” for assistance with these types of mental health issues. In the future, we intend to make use of both of these substances in psychotherapy.


Our present focus is on providing support in the integration of past psychedelic experiences into clients’ lives. We want to assist people in processing these sometimes challenging experiences and turning them into opportunities for personal growth and also to mitigate or prevent potential negative consequences (this practice is also known as harm reduction). Since the options for finding publicly available information on these matters are highly limited due to the illicit status of psychedelics, many people who have undergone a psychedelic experience can have difficulties finding professional help. Our clinic employs therapists who have had experience with this type of psychological support and assistance.


Since psychedelic research is now going through a worldwide re-awakening, we are seeing and expect to see continuing high demand for specially trained experts in the field of psychedelic-assisted psychotherapy. Courses completed by some of our therapists include the Certificate in Psychedelic-Assisted Therapies and Research (CPTR) at the Centre for Psychedelic Therapies and Research of the California Institute of Integral Studies (CIIS), the MDMA Therapy Training Program for PTSD provided by MAPS and the European training in psilocybin-assisted therapy for depression by Compass Pathways. Some of these therapists participate as field workers in the PsyCare harm reduction programme, which provides crisis intervention and psychological assistance for people dealing with difficult psychedelic experiences at music events and festivals. Many of these professionals are also involved in scientific studies and clinical trials of psychedelic substances. Our goal is to provide professionals with an interest in psychedelics with specialist training.

History of Psyon – Psychedelic Clinic

Psyon was founded as a therapeutic centre for people seeking assistance with issues related to the use of psychedelic substances and the need for psychotherapeutic counselling. The clinic’s goal is to become a leading provider of psychedelic-assisted psychotherapy.

The establishment of a therapeutic centre specializing in the clinical use of psychedelics has been a natural outcome of the “global renaissance” of interest in the research on the therapeutic use of psychedelics. The Czech Republic has a legacy of such psychedelic research dating back to the 1960s and 70s. The founding of Pyson was made possible by years of systematic research into the use of psychedelics by leading experts in the field, particularly Jiří Horáček, Tomáš Páleníček and their teams. The idea of actually creating a specialized clinic came about during Stanislav Milotinský’s and Filip Tylš’s participation in the Psychedelic-Assisted Therapies and Research Programme at the California Institute of Integral Studies (CIIS) in the USA. In May 2019, the company “Psychedelická klinika, s.r.o.” was set up by a team of 6 experts in the fields of psychotherapy, psychiatry, psychology, neurology and theoretical neuroscience. The team included Filip Tylš, Stanislav Milotinský, Jiří Horáček, Martin Brunovský, Tomáš Páleníček and Jaroslav Farkaš. The goal was to bring together their combined expertise in the understanding of the neurobiology as well as the psychological aspects of mental health issues. This combination of expertise sets the clinic apart from most other outpatient facilities, which tend to be strictly oriented on either pharmacology or psychotherapy.

What we have brought together is a community of psychotherapists who have special expertise in working with persons in need of integration following a difficult psychedelic experience and also with persons under the influence of psychedelics (e.g. who need care as part of the field work of the Psycare Harm Reduction Programme for CZEPS and during research studies at the Czech National Institute of Mental Health [NÚDZ]). Our specialist community collaborates and exchanges ideas and takes part in the development of  methodologies for psychedelic-assisted psychotherapy (PAP) as a new approach to treatment of mental illness.  Apart from their qualifications in the field of psychedelics, our therapists have extensive experience in standard psychotherapy (both short and longer-term) of various styles and approaches. This range of expertise is essential to our position as a clinic specializing on psychedelic-assisted psychotherapy.

The development of our psychedelic clinic has received financial support from the Miton investment group. Our therapeutic centre in Prague opened in January 2020 under the name Psyon – Psychedelic Clinic.

Psychedelic renaissance
A group of researchers including Jiří Horáček and Tomáš Páleníček revives the field of psychedelic research on human subjects at the Czech National Institute of Mental Health (NÚDZ), roughly 40 years after the ban was imposed on such psychedelic research in the former Czechoslovakia.
The idea of actually creating a specialized clinic comes about during Stanislav Milotinský’s and Filip Tylš’s participation in the Psychedelic-Assisted Therapies and Research Programme at the California Institute of Integral Studies (CIIS) in the USA.
Company “Psychedelická klinika, s.r.o.” is established with the support of the Miton investment group.
Therapeutic centre in Prague opens under the name Psyon – Psychedelic Clinic.

Clinic Management

The background of the clinic’s founders includes neuroscience research at the Czech National Institute of Mental Health (NÚDZ) (Jiří Horáček, Martin Brunovský, Tomáš Páleníček, Filip Tylš), clinical work with patients (Jiří Horáček, Martin Brunovský, Tomáš Páleníček, Filip Tylš, Stanislav Milotinský), management activities at the Czech Psychedelic Society, a non-profit organization (Filip Tylš, Stanislav Milotinský, Jaroslav Farkaš), and the Foundation for Psychedelic Science (Tomáš Páleníček, Jiří Horáček, Martin Brunovský), extensive psychotherapy and psychotherapeutic counselling (Filip Tylš, Stanislav Milotinský, Jaroslav Farkaš, Jiří Horáček, Tomáš Páleníček), international training in working with altered states of consciousness (Jiří Horáček), and training in Psychedelic-Assisted Therapies and Research (CPTR provided by the CIIS in San Francisco, CA, USA) (Filip Tylš, Stanislav Milotinský).